神经性厌食症与新型冠状病毒肺炎感染：临床病例报告
Anorexia nervosa and COVID-19 infection: Clinical case report.
作者信息
Simeunovic-Ostojic Mladena, Herremans Evy E, Thai Khoa, Maas Joyce
机构信息
Center for Eating Disorders Helmond Mental Health Center Region Oost-Brabant Boekel The Netherlands.
Star-shl Medical Diagnostic Center Rotterdam The Netherlands.
出版信息
Clin Case Rep. 2022 Sep 2;10(9):e6216. doi: 10.1002/ccr3.6216. eCollection 2022 Sep.
Abstract
The true risk of COVID-19 infection in anorexia nervosa (AN) including the duration of viral RNA shedding and infectivity is still unclear. We report on a case of a patient with severe AN with a mild course of COVID-19 and prolonged viral RNA shedding for at least 39 days after symptom onset. A careful evaluation of long-term infectivity must include viral load, live virus isolation, and viral genome sequencing.
摘要
神经性厌食症（AN）患者感染新型冠状病毒肺炎（COVID-19）的真实风险，包括病毒RNA脱落持续时间和传染性，目前仍不清楚。我们报告了1例患有严重AN的患者，其COVID-19病程较轻，但症状出现后病毒RNA脱落延长至少39天。对长期传染性的仔细评估必须包括病毒载量、活病毒分离和病毒基因组测序。
相似文献
1
Anorexia nervosa and COVID-19 infection: Clinical case report.
Clin Case Rep. 2022 Sep 2;10(9):e6216. doi: 10.1002/ccr3.6216. eCollection 2022 Sep.
2
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19.
Viruses. 2021 Oct 22;13(11):2133. doi: 10.3390/v13112133.
3
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
4
Trends in the Incidence of New-Onset Anorexia Nervosa and Atypical Anorexia Nervosa Among Youth During the COVID-19 Pandemic in Canada.
JAMA Netw Open. 2021 Dec 1;4(12):e2137395. doi: 10.1001/jamanetworkopen.2021.37395.
5
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.
6
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody.
BMC Infect Dis. 2024 Jul 22;24(1):715. doi: 10.1186/s12879-024-09631-3.
7
Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.
J Korean Med Sci. 2022 Oct 10;37(39):e289. doi: 10.3346/jkms.2022.37.e289.
8
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
9
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
10
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
本文引用的文献
1
COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship.
Obes Res Clin Pract. 2021 Nov-Dec;15(6):523-535. doi: 10.1016/j.orcp.2021.10.006. Epub 2021 Nov 3.
2
The Longest Infectious Virus Shedding in a Child Infected With the G614 Strain of SARS-CoV-2.
Pediatr Infect Dis J. 2021 Jul 1;40(7):e263-e265. doi: 10.1097/INF.0000000000003158.
3
The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis.
Diabetes Obes Metab. 2021 Jul;23(7):1701-1709. doi: 10.1111/dom.14382. Epub 2021 Apr 14.
4
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
5
Streamlining SARS-CoV-2 confirmatory testing to reduce false positive results.
J Clin Virol. 2021 Mar;136:104762. doi: 10.1016/j.jcv.2021.104762. Epub 2021 Feb 11.
6
Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes.
Neurosci Lett. 2021 Mar 23;748:135694. doi: 10.1016/j.neulet.2021.135694. Epub 2021 Feb 15.
7
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
J Infect Dis. 2021 May 20;223(9):1522-1527. doi: 10.1093/infdis/jiab075.
8
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
9
COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers.
J Eat Disord. 2021 Jan 20;9(1):15. doi: 10.1186/s40337-021-00369-w.
10
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).
Nat Commun. 2021 Jan 11;12(1):267. doi: 10.1038/s41467-020-20568-4.
Zotero 插件